About HS Code 300215
This HS code encompasses immunological products, whether human or animal-derived, that are prepared in measured doses or packaged for retail sale, and are *not* mixed. This category includes a wide array of finished biopharmaceutical products, such as single-component monoclonal antibodies, recombinant proteins, or specific immunoglobulins, ready for direct administration to patients. These are high-value, often prescription-only medicines used to treat various diseases, including autoimmune disorders, cancers, and infectious diseases. Importers are typically national health systems, pharmaceutical distributors, hospitals, and pharmacies, while exporters are leading global pharmaceutical and biotechnology companies. The trade is heavily regulated, requiring extensive clinical trials and marketing authorizations. Supply chain management is critical, involving cold chain logistics and secure distribution to ensure product efficacy and patient safety.
Products Under This Code
Monoclonal antibodies (single, retail), Recombinant human insulin (retail), Erythropoietin (EPO) injections (retail), Granulocyte-colony stimulating factor (G-CSF) injections (retail), Interferon alpha/beta injections (retail), Immunoglobulin G (single, retail), Diagnostic reagents (immunological, single, retail)
Real World Examples
Humira (adalimumab), Enbrel (etanercept), Remicade (infliximab), Herceptin (trastuzumab), Avastin (bevacizumab), Epogen (epoetin alfa), Neupogen (filgrastim)
Common Misclassification
This code is distinguished from 300214 by covering *unmixed* immunological products in retail packaging, whereas 300214 is for *mixed* products. It is also separate from vaccines (300241/300242).
Products Classified Under 3002.15
Industry
This code belongs to the Chemicals industry.
Trade Overview
Major players in the global trade of these finished immunological products include the USA, Switzerland, Germany, and Ireland.
Frequently Asked Questions
What is HS code 300215?
HS code 300215 covers: Blood, human or animal, antisera, other blood fractions and immunological products; immunological products, put up in measured doses or in forms or packings for retail sale. This HS code encompasses immunological products, whether human or animal-derived, that are prepared in measured doses or packaged for retail sale, and are *not* mixed. This category includes a wide array of finished biopharmaceutical products, such as single-component monoclonal antibodies, recombinant proteins, or specific immunoglobulins, ready for direct administration to patients. These are high-value, often prescription-only medicines used to treat various diseases, including autoimmune disorders, cancers, and infectious diseases. Importers are typically national health systems, pharmaceutical distributors, hospitals, and pharmacies, while exporters are leading global pharmaceutical and biotechnology companies. The trade is heavily regulated, requiring extensive clinical trials and marketing authorizations. Supply chain management is critical, involving cold chain logistics and secure distribution to ensure product efficacy and patient safety.
What products fall under HS code 300215?
Monoclonal antibodies (single, retail), Recombinant human insulin (retail), Erythropoietin (EPO) injections (retail), Granulocyte-colony stimulating factor (G-CSF) injections (retail), Interferon alpha/beta injections (retail), Immunoglobulin G (single, retail), Diagnostic reagents (immunological, single, retail)
What are common misclassifications for HS code 300215?
This code is distinguished from 300214 by covering *unmixed* immunological products in retail packaging, whereas 300214 is for *mixed* products. It is also separate from vaccines (300241/300242).
How is HS code 300215 structured?
HS code 300215 is a 6-digit subheading under the Harmonized System. The first 2 digits (30) identify the chapter, digits 3-4 (02) identify the heading, and digits 5-6 (15) specify the subheading. This code is standardized globally by the World Customs Organization.